Clinical Scorecard: Timing Considerations for Cranioplasty Following Decompressive Craniectomy in Traumatic Brain Injury: A Comprehensive Review and Meta-Analysis of Current Research and Trials

At a Glance

Key Highlights

• Decompressive craniectomy reduces mortality in refractory intracranial hypertension but increases risk of severe disability.
• Cranioplasty timing (early ≤ 90 days vs late > 90 days) remains controversial with inconsistent evidence on optimal timing.
• Early cranioplasty may improve neurological recovery and reduce operative time but may increase risk of hydrocephalus.

Guideline-Based Recommendations

Diagnosis

• Identify patients with refractory intracranial hypertension post-TBI requiring decompressive craniectomy.
• Assess cerebral swelling resolution prior to cranioplasty.

Management

• Perform cranioplasty after cerebral swelling subsides to restore skull protection.
• Consider early cranioplasty (≤ 90 days) for potential functional and technical benefits.
• Weigh risks of hydrocephalus and other complications when deciding timing.
• Select implant material (autologous, allogenic, synthetic) based on patient factors and timing.

Monitoring & Follow-up

• Monitor for postoperative complications including infection, fluid collections, and hydrocephalus.
• Assess neurological recovery and functional outcomes longitudinally post-cranioplasty.

Risks

• Early cranioplasty may increase hydrocephalus risk.
• Delayed cranioplasty may delay restoration of normal cranial physiology and neurorehabilitation benefits.
• Heterogeneity in timing definitions and implant materials may affect complication rates.

Patient & Prescribing Data

Adults with TBI undergoing decompressive craniectomy

Early cranioplasty (≤ 90 days) may reduce operative time and improve neurological recovery but requires careful risk assessment for complications such as hydrocephalus.

Clinical Best Practices

• Standardize definitions of early (≤ 90 days) and late (> 90 days) cranioplasty to reduce misclassification bias.
• Adjust for confounding factors including implant material and CSF shunt presence in outcome assessments.
• Individualize cranioplasty timing decisions based on patient-specific risks and benefits.
• Incorporate multidisciplinary input including neurosurgery and neurorehabilitation teams.
• Conduct further prospective studies to clarify optimal timing-material combinations for safety and efficacy.

References

• RESCUEicp trial on decompressive craniectomy outcomes
• Systematic review by Chasles et al. on cranioplasty timing
• CENTER-TBI and Net-QuRe multicentre prospective study